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Abstract: Earthworm extract has shown anticancer characteristics. In the present study, we examined the effect of chronic 
treatment with a high dose of earthworm (Eisenia andrei) extract (EE) on cell proliferation and neuroblast differentiation in the 
hippocampal dentate gyrus (DG) of 3-week-old mice using 5-bromo-2'-deoxyuridine (BrdU) and Ki-67 immunohistochemistry 
for cell proliferation and doublecortin (DCX) immunohistochemistry for neuroblast differentiation, respectively. BrdU-, Ki-
67-, and DCX-immunoreactive cells were easily detected in the subgranular zone of the DG in vehicle (saline)-treated mice. 
However, BrdU-, Ki-67-, and DCX-immunoreactive cells in the 500 mg/kg EE-treated mice decreased distinctively compared 
to those in the vehicle-treated mice. In addition, brain-derived neurotrophic factor (BDNF) immunoreactivity and its protein 
level decreased markedly in the DG of the EE-treated group compared to those in the vehicle-treated group. These results 
indicate that chronic treatment with high dose EE decreased cell proliferation and neuroblast differentiation, and that BDNF 
immunoreactivity decreased in the DG of EE-treated mice.
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and eventually integrate into pre-existing neural circuitry 
in the subgranular zone (SGZ) of the dentate gyrus (DG) 
in the hippocampus [1, 2]. Additionally, neurogenesis plays 
important roles in physiological, behavioral, and cognitive 
processes [1, 3, 4]. Recently, many researchers have focused 
on neurogenesis in relation to brain disorders such as 
ischemia, Alzheimer’s disease, and schizophrenia [5-8].
Earthworms are soil macroinvertebrate oligochaetes that 
play important roles sustaining soil fertility and productivity 
[9]. Many tribes in remote villages use earthworms to treat 
various kinds of ailments. Earthworm extract (EE) has 
dense nutritional content and is widely used in Chinese 
traditional medicine [10]. Extraction and use of biologically 
active compounds from earthworms have been traditionally 
Introduction
Neurogenesis in the adult brain is well defined as a process 
of functionally generating neural cell types from adult neural 
precursor cells, and neurogenesis occurs in two discrete 
areas of the mammalian brain [1]. Adult neural precursor 
cells undergo cell proliferation, maturation, and migration Neurogenic effects of Eisenia andrei
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practiced by indigenous people throughout the world, more 
particularly in Asia, including China, India, Myanmar, Korea, 
and Vietnam [11]. 
EE shows antithrombotic characteristics [12]. However, 
Cooper et al. [13] reported that EE shows anticancer charac-
teristics. In addition, there are reports on the inhibition 
of adult neural progenitor cell proliferation by EE [14-
16]. Therefore, in the present study, we examined whether 
chronic treatment with high dose EE affects cell proliferation 
and neuroblast differentiation in the mouse hippocampal 
DG using 5-bromo-2'-deoxyuridine (BrdU), Ki-67, and 
doublecortin (DCX) immunohistochemistry. 
Materials and Methods 
Preparation of EE
Earthworms, Eisenia andrei, were vermicultured at a 
breeding center. Briefly, the live earthworms were washed 
with distilled water to clean attached mud, homogenized, 
and then centrifuged at 4,500 ×g and 4°C for 60 minutes. 
The supernatant was filtered with Celite, and 95% ethanol 
was added to the filtered solution to make a 40-80% ethanol 
solution, which was centrifuged at 4,500 ×g and 4°C for 60 
minutes. The precipitate was resuspended in distilled water 
and filtered with a 0.45 µm membrane filter followed by an 
ultra filter (NMWC 10,000). The ultra-filtered solution was 
lyophilized, and the resultant powder was obtained. 
Experimental animals
Three-week-old male ICR mice were purchased from 
Orient Bio Inc. (Seongnam, Korea). They were housed under 
standard conditions with proper temperature (23°C) and 
humidity (60%) control and a 12 hour light/12 hour dark 
cycle with free access to food and water. The procedures for 
handling and caring for the animals adhered to the guidelines 
that are in compliance with current international laws and 
policies (NIH Guide for the Care and Use of Laboratory 
Animals, NIH Publication No. 85-23, 1985, revised 1996), and 
they were approved by the Institutional Animal Care and Use 
Committee at Hallym’s Medical Center. All experiments were 
conducted to minimize the number of animals used and the 
suffering caused by the procedures used in the present study.
Treatment with EE
Mice were divided into four groups (n=7/group): vehicle 
(10 ml saline/kg body weight), 50 mg/kg EE, 100 mg/kg EE, 
and 500 mg/kg EE (50, 100, and 500 mg, respectively, in 10 
ml saline/kg body weight)-treated groups. To investigate the 
effects of EE on cell proliferation and neuroblast differen-
tiation in the SGZ of the DG, vehicle or EE was administered 
orally using an 18-gauge feeding needle (Harvard Apparatus, 
Holliston, MA, USA) once per day for 3 months before 
sacrifice. EE was administrated orally, because EE is always 
taken orally in traditional medicine. To determine the 
number of new cells generated in the adult brain, the animals 
were treated three times with an intraperitoneal injection of 
50 mg/kg/day BrdU (Sigma, St. Louis, MO, USA) on days 70 
and 80; BrdU-positive cells included both newly-generated 
cells and those that survived 10 and 20 days later.
Immunohistochemistry
Vehicle- and EE-treated animals were anesthetized with 
sodium pentobarbital and perfused transcardially with 0.1 
M phosphate-buffered saline (PBS, pH 7.4) followed by 4% 
paraformaldehyde in 0.1 M phosphate-buffer (pH 7.4). Brains 
were removed and fixed in the same fixative for 4 hours. Brain 
tissues were cryoprotected by infiltration with 30% sucrose 
overnight. Thereafter, frozen tissues were serially sectioned 
on a cryostat (Leica, Wetzlar, Germany) into 25 μm coronal 
sections, and the sections were collected into six-well plates 
containing PBS. The tissue sections were selected according to 
anatomical landmarks corresponding to bregma -1.46 to -2.46 
mm of the mouse brain atlas.
The sections were sequentially treated with 0.3% hydrogen 
peroxide in PBS for 30 minutes and 10% normal goat 
serum in 0.05 M PBS for 30 minutes. The sections were 
then incubated with diluted mouse anti-BrdU (1 : 200, 
Chemicon International, Temecula, CA, USA), rabbit anti-
Ki-67 (1 : 100, Abcam, Cambridge, UK), goat anti-DCX (1 : 
500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and 
rabbit anti-brain derived neurotrophic factor (BDNF; 1 : 500, 
Abcam) overnight at 4°C. Then, the sections were exposed 
to biotinylated goat anti-rabbit, goat anti-mouse, or rabbit 
anti-goat IgG (1 : 200, Vector Laboratories, Burlingame, 
CA, USA) and streptavidin peroxidase complex (1 : 200, 
Vector Laboratories). The sections were visualized with 
3, 3'-diaminobenzidine tetrahydrochloride in 0.1 M Tris-
HCl buffer and mounted on gelatin-coated slides. After 
dehydration, the sections were mounted in Canada balsam 
(Kanto Chemical, Tokyo, Japan). To establish immunostaining 
specificity, a negative control test was performed with pre-Anat Cell Biol 2011;44:218-225 Bing Chun Yan, et al 220
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immune serum rather than primary antibody. The negative 
control resulted in the absence of immunoreactivity in 
all structures. To understand the effects of EE on cell 
proliferation in mice, the total number of Ki-67 positive cells 
in all groups was counted in the DG in 15 sections/animal 
using an image analyzing system equipped with a computer-
based CCD camera software (Optimas 6.5, CyberMetrics, 
Scottsdale, AZ, USA). Cell counts were obtained by averaging 
the counts from the sections taken from each animal.
Western blot analysis
To examine the effects of EE on BDNF level in the DG, 
Fig. 1. Immunohistochemistry for 5-bromo-2'-deoxyuridine (BrdU) in the hippocampal dentate gyrus (DG) of the vehicle- (A, B) and earthworm 
extract (EE)-treated (C, D) groups. BrdU
+ cells (arrows) in the DG of the EE-treated group were lower than those in the vehicle­treated group. 
GCL, granule cell layer; ML, molecular layer; PL, polymorphic layer; SGZ, subgranular layer. Scale bar=100 μm. (E) Mean number of BrdU
+ cells 
per section in the vehicle­ and EE­treated groups (n=7/group; *P<0.05, significantly different from the vehicle­treated group).Neurogenic effects of Eisenia andrei
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the animals (n=5/group) were used for Western blot analysis. 
After sacrificing the animals and removing the brains, the 
brains were serially and transversely cut to a thickness of 
400 μm on a vibratome (Leica), and the DG was dissected 
with a surgical blade. The tissues were homogenized in 50 
mM PBS (pH 7.4) containing EGTA (pH 8.0), 0.2% NP-40, 
10 mM EDTA (pH 8.0), 15 mM sodium pyrophosphate, 100 
mM β-glycerophosphate, 50 mM NaF, 150 mM NaCl, 2 mM 
sodium orthvanadate, 1 mM phenylmethanesulfonylfluoride, 
and 1 mM dithiothreitol (DTT). After centrifugation, the 
protein level in the supernatants was determined using a 
Micro BCA Protein Assay kit with bovine serum albumin as 
the standard (Pierce Chemical, Rockford, IL, USA). Aliquots 
containing 50 μg of total protein were boiled in loading buffer 
containing 250 mM Tris (pH 6.8), 10 mM DTT, 10% sodium 
dodecyl sulfate, 0.5% bromophenol blue, and 50% glycerol. 
The aliquots were then loaded onto a suitable polyacrylamide 
gel. After electrophoresis, the gels were transferred to 
nitrocellulose transfer membranes (Pall Crop, East Hills, NY, 
USA). To reduce background staining, the membranes were 
incubated with 5% non-fat dry milk in TBS containing 0.1% 
Tween20 for 45 minutes, followed by an incubation with 
BDNF (1 : 1,000, Abcam) overnight at 4°C and subsequently 
exposed to peroxidase-conjugated horse anti-rabbit IgG 
(Santa Cruz Biotechnology) and an ECL kit (Amersham, 
Piscataway, NJ, USA). The results of the Western blot analysis 
were scanned, and densitometric analysis to quantify the 
bands was performed using Scion Image software (Scion 
Corp., Frederick, MD, USA), which was used to count relative 
optical density (ROD). The ratio of the ROD was calibrated as 
%, with the sham group designated as 100%.
Statistical analysis
Data are presented as means±SEMs. Differences among 
means were statistically analyzed using a two-tailed Student’s 
t-test to understand the effects of EE on cell proliferation and 
neuroblast differentiation in mice. A P<0.05 was considered 
statistically significant.
Results
We administered 50, 100, and 500 mg/kg (n=7/group), 
and we obtained significant data for cell proliferation (Ki-
67) and neuroblast differentiation (DCX) only in the 500 mg/
kg EE-treated group. We could not identify any physiological 
changes, such as changes in body weight, hair condition, or 
grooming (data not shown).
Cell proliferation 
BrdU-immunoreactive (+) cells were mainly detected 
in the SGZ of the DG. Many BrdU
+ cells were observed in 
the vehicle-treated group (Fig. 1A, B). The mean number 
of BrdU
+ cells was about 30 per section in the DG (Fig. 1E). 
However, BrdU
+ cells decreased significantly in the EE-treated 
group (Fig. 1C, D). The mean number of BrdU
+ cells was 
approximately nine per section in the DG (Fig. 1E).
Ki-67
+ cells were also mainly detected in the SGZ of 
the DG. Ki-67
+ cells were clearly observed in the vehicle-
treated group (Fig. 2A, B). The mean number of Ki-67
+ was 
approximately 12 per DG section (Fig. 2E); however, Ki-67
+ 
cells decreased distinctly in the EE-treated group (Fig. 2C, D). 
The mean number was about six per section in the DG (Fig. 2E).
Neuroblast differentiation
DCX
+ neuroblasts were clearly observed in the DG of 
the vehicle-treated group (Fig. 3A, B). Their cell bodies 
were located in the SGZ, and their processes projected into 
the molecular layer of the DG. The mean number of DCX
+ 
neuroblasts was about 40 per section in the DG (Fig. 3E). 
DCX immunoreactivity decreased significantly in the EE-
treated group, and DCX
+ processes became very short (Figs. 
2D, 3C). The mean number of DCX
+ neuroblasts was about 
20 per section in the DG (Fig. 3E).
BDNF immunoreactivity and its protein level
BDNF immunoreactivity was observed in the DG of the 
vehicle-treated group (Fig. 4A), and immunoreactivity was 
high in the granules and polymorphic cells. However, weak 
BDNF immunoreactivity was found in the EE-treated group 
compared with that in the vehicle-treated group (Fig. 4B).
The changes in the BDNF protein levels were similar to the 
immunohistochemical changes (Fig. 4C). The BDNF level was 
high in the vehicle-treated group, whereas the BDNF level 
decreased significantly in the EE-treated group compared to 
that in the vehicle-treated group.
Discussion
In this study, we examined the effects of chronic EE treat-
ment on cell proliferation and neuroblast differentiation Anat Cell Biol 2011;44:218-225 Bing Chun Yan, et al 222
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in the SGZ of the DG in mice. EE has been generally used 
at a dose <300 mg/kg in studies on anti-inflammatory and 
antioxidant effects [9, 17]. However, in the present study, no 
obvious changes in the number of BrdU
+, Ki-67
+, or DCX
+ 
cells were found in the 50 and 100 mg/kg EE-treated groups; 
only in the high dose (500 mg/kg) EE-treated group did we 
find distinctive decreases in the number of BrdU
+, Ki-67
+, and 
DCX
+ cells. 
Furthermore, the arborization of DCX
+ processes in the 
DC of the EE-treated group was much worse than that in 
Fig. 2. Immunohistochemistry for Ki-67 in the hippocampal dentate gyrus of the vehicle- (A, B) and earthworm extract (EE)-treated (C, D) 
groups. Fewer Ki-67
+ cells (arrows) were evident in the EE-treated group than those in the vehicle-treated group. GCL, granule cell layer; ML, 
molecular layer; PL, polymorphic layer; SGZ, subgranular layer. Scale bar=100 μm. (E) Mean number of Ki-67
+ cells per section in the vehicle- and 
EE-treated groups (n=7/group; *P<0.05, significantly different from the vehicle­treated group).Neurogenic effects of Eisenia andrei
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the vehicle-treated group. These results demonstrate that 
chronic 500 mg/kg EE treatment decreased cell proliferation 
and neuroblast differentiation in the SGZ of mice. DG ex-
hibits cytolytic, fibrinolytic, anticoagulant, proteolytic, hemo-
lytic, mitogenic, and antibacterial activities [10, 11, 18]. 
Furthermore, some researchers have reported that EE has a 
lethal effect on cancer cells [13, 19]. 
In this study, we observed a decease in BDNF immuno-
reactivity in the mouse DG after chronic EE treat  ment. 
Rosiglitazone, an agonist of peroxisome proliferator-activated 
Fig. 3. Immunohistochemistry for doublecortin (DCX) in the hippocampal dentate gyrus of the vehicle- (A, B) and earthworm extract (EE)-
treated (C, D) groups. DCX
+ neuroblasts (arrows) were abundant, and DCX
+ processes were well stained in the vehicle­treated group. However, 
DCX immunoreactivity in the EE-treated group decreased markedly. GCL, granule cell layer; ML, molecular layer; PL, polymorphic layer; SGZ, 
subgranular layer. Scale bar=100 μm. (E) Mean number of DCX
+ cells per section in the vehicle­ and EE­treated groups (n=7/group; *P<0.05, 
significantly different from the vehicle­treated group).Anat Cell Biol 2011;44:218-225 Bing Chun Yan, et al 224
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receptor γ, decreases BDNF and glial cell line-derived neu-
rotrophic factor levels and also decreases cell proliferation 
and neuroblast differentiation in the mouse DG [20]. Many 
studies have reported that neurotrophic factors including 
BDNF may act as positive regulators of neurogenesis [21, 22]. 
Additionally, exogenous BDNF increases the proliferation 
of hippocampal neural progenitor cells in rats [23, 24]. It 
has been reported that BDNF-mediated neuronal precursor 
cell differentiation and survival inside neurospheres occurs 
by activating signaling pathways that are transduced by 
AKT, ERK1/2, and STAT-3 [25]. Therefore, in this study, the 
decreased BDNF immunoreactivity may provide evidence of 
decreased cell proliferation and neuroblast differentiation in 
the SGZ after chronic EE treatment.
In conclusion, a chronic 500 mg/kg EE treatment 
decreased the number of BrdU
+, Ki-67
+, and DCX
+ cells in the 
mouse DG, and BDNF immunoreactivity and its protein level 
decreased in mouse DGs chronically treated with 500 mg/kg 
EE.
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